Skip to main content

Table 5 Multinomial regression of predictive factors associated with treatment success rate among patients treated for TB

From: Tuberculosis treatment outcome among patients treated in public primary healthcare facility, Addis Ababa, Ethiopia: a retrospective study

  

COR (95% CI)

 

AOR (95% CI)

Cured Vs unsuccessful treatment outcome

B(SE)

 

B(SE)

 

Age category, in years

−0.02 (0.02)

0.97 (0.94–0.0.99)*

− 0.04 (0.05)

0.91 (0.71–2.33)

HIV status

Positive

 

1.00

 

1.00

Negative

2.2 (0.35)

8.78 (4.41–17.51)**

2.34 (1.8)

6.1 (2.1–13.9)*

Unknown

1.8 (1.1)

6.00 (0.72–13.1)

0.64 (1.68)

1.9 (0.07–51.4)

Type of TB

Extra PTB

 

1.00

 

1.00

Smear positive PTB

2.8 (0.46)

17.8 (7.2–43.8)**

4.66 (1.2)

10.5 (5.36–16.31)**

Smear negative PTB

−1.4 (0.65)

0.25 (0.071–0.89)*

− 0.27 (1.1)

0.77 (0.09–6.58)

TB treatment category

New

 

1.00

 

1.00

Retreatment

−1.6 (0.27)

0.52 (0.34–0.86)*

− 1.1 (0.22)

0.31 (0.05–0.59)

Transfer in

0.85 (0.69)

2.33 (0.60–9.02)

0.54 (0.39)

2.01 (0.87–3.65)

Treatment completed Vs unsuccessful treatment outcome

Age category in years

−0.03 (0.02)

0.97 (0.93–0.95)*

− 0.016 (0.81)

0.99 (0.81–2.99)

HIV status

Positive

 

1.00

 

1.00

Negative

3.1 (0.34)

21.4 (10.9–39.8)**

2.07 (1.13)

4.4 (1.26–15.58)*

Unknown

0.65 (0.0.37)

1.9 (0.92–3.91)

0.18 (1.1)

2.84 (0.096–7.3)

Type of TB

Extra PTB

 

1.00

 

1.00

Smear positive PTB

2.2 (0.31)

9.1 (5.00–16.5)**

4.26 (1.28)

3.8 (1.25–7.4)**

Smear negative PTB

3.46 (0.51)

2.88 (1.17–7.39)**

0.91 (0.62)

1.73 (0.12–4.34)

TB treatment category

New

 

1.00

 

1.00

Re-treatment

−1.3 (0.67)

0.273 (0.024–0.81)*

− 1.9 (0.86)

0.15 (0.03–0.99)

Transfer in

0.11 (1.04)

1.42 (0.62–7.2)

3.2 (1.65)

2.11 (0.65–3.88)

  1. Note: R2 = 0.645 (Cox & Snell), 0.813 (Nagelkerke); Model χ2 = 364.7, Pearson (p = 0.73) and deviance(p = 0.894); * p < .05, ** p < .001